Zim’s Lenacapavir lottery: A tale of two worlds

IN the bustling streets of Epworth, 18-year-old Tadiwanashe Moyo, clutches a tattered piece of paper, her eyes scanning it with a mixture of hope and trepidation.  

This slip of paper holds the key to her future — a golden ticket to receive the long-awaited Lenacapavir injection, a revolutionary HIV prevention drug that promises to change the trajectory of her life. 

But as Moyo walks the narrow, dusty and pot-holed streets of her neighbourhood, she hardly notices similar circumstances surrounding her. 

This story is for NewsDay subscribers.